inTEST Q4 revenue up 50% YoY to $22.4M; guides FY2022 revenue $110M-$115M

INTEST CORP

Q4 revenue $22.4M (+50% YoY); GAAP EPS $0.03 vs loss $0.04 prior year.
Record quarterly orders $30.5M (front-end semi); annual orders $101.9M.
Three acquisitions in Q4 contributed $1.5M revenue; expanding into security, life sciences.
Guidance: FY2022 revenue $110M-$115M (over 30% growth at midpoint).
Gross margin improved to 46.3% from 45.2%, but supply chain and inflation pressures noted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.